AI Tokens
Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Two-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Sep 30, 2026 11.50% = 4.02% × 2.86
Jun 30, 2026 11.06% = 3.93% × 2.82
Mar 31, 2026 11.94% = 4.17% × 2.87
Dec 31, 2025 12.90% = 4.66% × 2.77
Sep 30, 2025 12.59% = 4.51% × 2.79
Jun 30, 2025 12.26% = 4.40% × 2.79
Mar 31, 2025 13.92% = 4.94% × 2.82
Dec 31, 2024 14.47% = 5.12% × 2.83
Sep 30, 2024 14.66% = 5.51% × 2.66
Jun 30, 2024 15.86% = 5.92% × 2.68
Mar 31, 2024 15.38% = 5.58% × 2.76
Dec 31, 2023 15.23% = 5.50% × 2.77
Sep 30, 2023 15.82% = 5.50% × 2.88
Jun 30, 2023 16.78% = 5.87% × 2.86
Mar 31, 2023 16.62% = 5.69% × 2.92
Dec 31, 2022 16.59% = 5.86% × 2.83
Sep 30, 2022 17.26% = 6.03% × 2.86
Jun 30, 2022 17.04% = 6.05% × 2.82
Mar 31, 2022 17.36% = 6.21% × 2.79

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) exhibits a consistent long-term downward trajectory, decreasing from 17.36% in March 2022 to 11.50% by September 2026. This decline is primarily driven by a contraction in asset productivity rather than modifications in the capital structure.

Return on Assets (ROA)
A sustained decline in ROA is observed throughout the analyzed period, falling from a peak of 6.21% in the first quarter of 2022 to 4.02% by the third quarter of 2026. While the decrease was gradual through 2023, a more pronounced compression occurred between December 2023 (5.50%) and June 2025 (4.40%), indicating a reduction in the entity's ability to generate earnings relative to its total asset base.
Financial Leverage
The financial leverage ratio remained relatively stable, fluctuating within a narrow corridor between a minimum of 2.66 in September 2023 and a maximum of 2.92 in March 2023. The absence of a significant trend in this ratio suggests that the overall risk profile and the proportion of debt used to finance assets remained constant over the period.
ROE Disaggregation Analysis
The two-component DuPont analysis reveals that the erosion of ROE is almost exclusively attributable to the diminishing ROA. Because the financial leverage ratio remained neutral, it did not provide the necessary amplification to offset the decline in operational efficiency. Consequently, the ROE closely mirrored the downward movement of the ROA, resulting in a total reduction of 5.86 percentage points over the observed timeframe.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Three-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Sep 30, 2026 11.50% = 2.58% × 1.56 × 2.86
Jun 30, 2026 11.06% = 2.50% × 1.57 × 2.82
Mar 31, 2026 11.94% = 2.64% × 1.58 × 2.87
Dec 31, 2025 12.90% = 2.87% × 1.63 × 2.77
Sep 30, 2025 12.59% = 2.86% × 1.57 × 2.79
Jun 30, 2025 12.26% = 2.85% × 1.54 × 2.79
Mar 31, 2025 13.92% = 3.26% × 1.52 × 2.82
Dec 31, 2024 14.47% = 3.41% × 1.50 × 2.83
Sep 30, 2024 14.66% = 3.72% × 1.48 × 2.66
Jun 30, 2024 15.86% = 3.93% × 1.51 × 2.68
Mar 31, 2024 15.38% = 3.66% × 1.52 × 2.76
Dec 31, 2023 15.23% = 3.52% × 1.56 × 2.77
Sep 30, 2023 15.82% = 3.63% × 1.52 × 2.88
Jun 30, 2023 16.78% = 3.89% × 1.51 × 2.86
Mar 31, 2023 16.62% = 3.89% × 1.46 × 2.92
Dec 31, 2022 16.59% = 3.87% × 1.51 × 2.83
Sep 30, 2022 17.26% = 4.09% × 1.48 × 2.86
Jun 30, 2022 17.04% = 4.13% × 1.47 × 2.82
Mar 31, 2022 17.36% = 4.37% × 1.42 × 2.79

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) exhibits a consistent downward trajectory over the analyzed period, declining from 17.36% in March 2022 to 11.50% by September 2026. While the ROE remained relatively stable above 15% through the end of 2023, a more pronounced acceleration in the decline occurred throughout 2024 and 2025, reaching a periodic low of 11.06% in June 2026 before a slight recovery.

Net Profit Margin
A sustained contraction in profitability is observed, serving as the primary driver for the decline in ROE. The margin decreased from 4.37% in March 2022 to 2.58% in September 2026. This compression was gradual through 2022 and 2023 but intensified starting in 2024, with the margin falling below 3% by June 2025 and remaining at depressed levels thereafter.
Asset Turnover
Asset utilization showed a general trend of improvement, partially offsetting the decline in profit margins. The turnover ratio increased from 1.42 in March 2022 to a peak of 1.63 in December 2025, ending the period at 1.56. This indicates an increase in the efficiency of assets in generating revenue, although the gains were insufficient to compensate for the eroding net margins.
Financial Leverage
The financial leverage ratio remained relatively stable throughout the period, fluctuating within a narrow range between 2.66 and 2.92. Because the leverage multiplier did not shift significantly, it provided a constant amplification effect but contributed no momentum toward reversing the downward trend in ROE.

The DuPont disaggregation reveals that the overall reduction in equity returns is fundamentally a result of margin erosion. The operational efficiency gained through higher asset turnover and the consistent use of financial leverage were unable to neutralize the impact of the declining net profit margin, leading to a weakened return profile over the five-year span.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Five-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Sep 30, 2026 11.50% = 0.82 × 0.81 × 3.88% × 1.56 × 2.86
Jun 30, 2026 11.06% = 0.84 × 0.80 × 3.68% × 1.57 × 2.82
Mar 31, 2026 11.94% = 0.84 × 0.81 × 3.85% × 1.58 × 2.87
Dec 31, 2025 12.90% = 0.84 × 0.83 × 4.11% × 1.63 × 2.77
Sep 30, 2025 12.59% = 0.78 × 0.84 × 4.39% × 1.57 × 2.79
Jun 30, 2025 12.26% = 0.76 × 0.84 × 4.47% × 1.54 × 2.79
Mar 31, 2025 13.92% = 0.76 × 0.86 × 4.97% × 1.52 × 2.82
Dec 31, 2024 14.47% = 0.76 × 0.87 × 5.19% × 1.50 × 2.83
Sep 30, 2024 14.66% = 0.77 × 0.88 × 5.46% × 1.48 × 2.66
Jun 30, 2024 15.86% = 0.78 × 0.89 × 5.66% × 1.51 × 2.68
Mar 31, 2024 15.38% = 0.78 × 0.89 × 5.33% × 1.52 × 2.76
Dec 31, 2023 15.23% = 0.78 × 0.88 × 5.14% × 1.56 × 2.77
Sep 30, 2023 15.82% = 0.78 × 0.89 × 5.27% × 1.52 × 2.88
Jun 30, 2023 16.78% = 0.77 × 0.90 × 5.64% × 1.51 × 2.86
Mar 31, 2023 16.62% = 0.77 × 0.90 × 5.60% × 1.46 × 2.92
Dec 31, 2022 16.59% = 0.77 × 0.90 × 5.54% × 1.51 × 2.83
Sep 30, 2022 17.26% = 0.77 × 0.91 × 5.83% × 1.48 × 2.86
Jun 30, 2022 17.04% = 0.77 × 0.91 × 5.89% × 1.47 × 2.82
Mar 31, 2022 17.36% = 0.77 × 0.91 × 6.24% × 1.42 × 2.79

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


A comprehensive analysis of the five-component DuPont disaggregation reveals a sustained decline in the Return on Equity (ROE), which decreased from 17.36% in March 2022 to 11.50% by September 2026. This erosion in shareholder returns is primarily driven by significant compression in operating profitability, which was not sufficiently offset by gains in asset efficiency or changes in financial leverage.

Operating Profitability and Margin Trends
The EBIT margin exhibits a consistent downward trajectory throughout the period. Starting at 6.24% in March 2022, the margin declined steadily to a low of 3.68% in June 2026 before a marginal recovery to 3.88% in September 2026. This compression represents the most significant negative driver of the overall ROE decline, indicating rising operating costs or pricing pressures relative to revenue.
Interest and Tax Burden Analysis
The interest burden ratio shows a gradual decline from 0.91 in early 2022 to 0.81 by September 2026, suggesting that a larger portion of operating income is being consumed by interest expenses over time. Conversely, the tax burden ratio remained stable around 0.77 for several years before trending upward to 0.82 by the end of the period. The increase in the tax burden ratio indicates a reduction in the effective tax rate, which provided a slight positive offset to the declining net margins in the final years of the analysis.
Asset Efficiency and Utilization
Asset turnover demonstrates a general improvement, rising from 1.42 in March 2022 to a peak of 1.63 in December 2025, eventually settling at 1.56 in September 2026. This trend suggests an increase in the company's ability to generate revenue from its asset base, reflecting improved operational efficiency in asset utilization.
Financial Leverage and Capital Structure
Financial leverage remained relatively stable, fluctuating within a narrow range between 2.66 and 2.92. While there were minor oscillations—such as a dip to 2.66 in September 2024 followed by a return to 2.86 by September 2026—leverage did not serve as a primary catalyst for the changes in ROE, indicating a consistent approach to the company's debt-to-equity profile.

In summary, the decline in ROE is the result of a fundamental contraction in operating margins and an increasing interest burden. While the organization successfully improved its asset turnover and benefited from a lower effective tax rate in the later periods, these improvements were insufficient to counteract the significant erosion of the EBIT margin.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Two-Component Disaggregation of ROA

Elevance Health Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Sep 30, 2026 4.02% = 2.58% × 1.56
Jun 30, 2026 3.93% = 2.50% × 1.57
Mar 31, 2026 4.17% = 2.64% × 1.58
Dec 31, 2025 4.66% = 2.87% × 1.63
Sep 30, 2025 4.51% = 2.86% × 1.57
Jun 30, 2025 4.40% = 2.85% × 1.54
Mar 31, 2025 4.94% = 3.26% × 1.52
Dec 31, 2024 5.12% = 3.41% × 1.50
Sep 30, 2024 5.51% = 3.72% × 1.48
Jun 30, 2024 5.92% = 3.93% × 1.51
Mar 31, 2024 5.58% = 3.66% × 1.52
Dec 31, 2023 5.50% = 3.52% × 1.56
Sep 30, 2023 5.50% = 3.63% × 1.52
Jun 30, 2023 5.87% = 3.89% × 1.51
Mar 31, 2023 5.69% = 3.89% × 1.46
Dec 31, 2022 5.86% = 3.87% × 1.51
Sep 30, 2022 6.03% = 4.09% × 1.48
Jun 30, 2022 6.05% = 4.13% × 1.47
Mar 31, 2022 6.21% = 4.37% × 1.42

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


An analysis of the Return on Assets (ROA) over the period from March 31, 2022, to September 30, 2026, reveals a sustained downward trajectory. ROA declined from a peak of 6.21% to 4.02%, indicating a reduction in the company's ability to generate profit from its asset base. This decline is the result of contrasting movements between net profit margins and asset turnover.

Net Profit Margin Trends
A consistent and significant compression of the net profit margin is observed throughout the analyzed timeframe. The margin decreased from 4.37% in March 2022 to 2.58% by September 2026. While there were minor periodic fluctuations—such as a slight recovery to 3.93% in June 2024—the long-term trend remains negative, reflecting a systematic erosion of profitability per dollar of revenue.
Asset Turnover Efficiency
In contrast to the profit margin, asset turnover generally trended upward, indicating improved operational efficiency in utilizing assets to generate revenue. The ratio rose from 1.42 in March 2022 to a peak of 1.63 in December 2025, before stabilizing around 1.56 by the end of the period. This suggests that the company successfully increased its revenue throughput relative to its asset base.
ROA Disaggregation and Primary Drivers
The two-component disaggregation reveals that the overall decline in ROA was driven exclusively by the contraction of the net profit margin. The modest gains achieved in asset turnover were insufficient to offset the impact of shrinking margins. For instance, between December 2024 and December 2025, the asset turnover improved from 1.50 to 1.63, yet ROA fell from 5.12% to 4.66% because the net profit margin dropped simultaneously from 3.41% to 2.87%.

The cumulative effect of these trends demonstrates a shift in the company's financial profile, where increased asset productivity has been overshadowed by a persistent decline in bottom-line profitability, leading to a weakened overall return on assets.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Four-Component Disaggregation of ROA

Elevance Health Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Sep 30, 2026 4.02% = 0.82 × 0.81 × 3.88% × 1.56
Jun 30, 2026 3.93% = 0.84 × 0.80 × 3.68% × 1.57
Mar 31, 2026 4.17% = 0.84 × 0.81 × 3.85% × 1.58
Dec 31, 2025 4.66% = 0.84 × 0.83 × 4.11% × 1.63
Sep 30, 2025 4.51% = 0.78 × 0.84 × 4.39% × 1.57
Jun 30, 2025 4.40% = 0.76 × 0.84 × 4.47% × 1.54
Mar 31, 2025 4.94% = 0.76 × 0.86 × 4.97% × 1.52
Dec 31, 2024 5.12% = 0.76 × 0.87 × 5.19% × 1.50
Sep 30, 2024 5.51% = 0.77 × 0.88 × 5.46% × 1.48
Jun 30, 2024 5.92% = 0.78 × 0.89 × 5.66% × 1.51
Mar 31, 2024 5.58% = 0.78 × 0.89 × 5.33% × 1.52
Dec 31, 2023 5.50% = 0.78 × 0.88 × 5.14% × 1.56
Sep 30, 2023 5.50% = 0.78 × 0.89 × 5.27% × 1.52
Jun 30, 2023 5.87% = 0.77 × 0.90 × 5.64% × 1.51
Mar 31, 2023 5.69% = 0.77 × 0.90 × 5.60% × 1.46
Dec 31, 2022 5.86% = 0.77 × 0.90 × 5.54% × 1.51
Sep 30, 2022 6.03% = 0.77 × 0.91 × 5.83% × 1.48
Jun 30, 2022 6.05% = 0.77 × 0.91 × 5.89% × 1.47
Mar 31, 2022 6.21% = 0.77 × 0.91 × 6.24% × 1.42

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Assets (ROA) exhibits a long-term decelerating trend, declining from 6.21% in March 2022 to 4.02% by September 2026. While periodic fluctuations occurred, the overall trajectory indicates a sustained reduction in the company's ability to generate net income from its asset base.

Operating Profitability
A significant and consistent decline is observed in the EBIT Margin, which contracted from 6.24% in March 2022 to 3.88% in September 2026. This margin compression serves as the primary driver for the deterioration of ROA, suggesting that operating expenses have grown at a faster rate than operating revenues over the analyzed period.
Asset Utilization
Conversely, Asset Turnover demonstrates a general upward trend, improving from 1.42 in March 2022 to 1.56 in September 2026, with a peak of 1.63 in December 2025. This indicates an increase in operational efficiency, as the company successfully generated higher revenue per unit of asset, partially offsetting the decline in profit margins.
Interest Burden
The Interest Burden ratio shows a steady decline from 0.91 in early 2022 to 0.81 by September 2026. This downward trend indicates that a larger portion of operating income is being allocated to interest payments, reflecting an increase in the relative cost of debt servicing over time.
Tax Burden
The Tax Burden remained largely stagnant between 0.76 and 0.78 for the majority of the period. However, a notable increase is observed starting in December 2025, peaking at 0.84 in the first quarter of 2026. This increase suggests a reduction in the effective tax rate, which provided a marginal boost to net income toward the end of the timeline.

In summary, the analysis reveals a divergence between efficiency and profitability. Although the company improved its asset turnover and benefited from a lower effective tax rate in the final quarters, these improvements were insufficient to counteract the simultaneous contraction of EBIT margins and the rising burden of interest expenses.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Disaggregation of Net Profit Margin

Elevance Health Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Sep 30, 2026 2.58% = 0.82 × 0.81 × 3.88%
Jun 30, 2026 2.50% = 0.84 × 0.80 × 3.68%
Mar 31, 2026 2.64% = 0.84 × 0.81 × 3.85%
Dec 31, 2025 2.87% = 0.84 × 0.83 × 4.11%
Sep 30, 2025 2.86% = 0.78 × 0.84 × 4.39%
Jun 30, 2025 2.85% = 0.76 × 0.84 × 4.47%
Mar 31, 2025 3.26% = 0.76 × 0.86 × 4.97%
Dec 31, 2024 3.41% = 0.76 × 0.87 × 5.19%
Sep 30, 2024 3.72% = 0.77 × 0.88 × 5.46%
Jun 30, 2024 3.93% = 0.78 × 0.89 × 5.66%
Mar 31, 2024 3.66% = 0.78 × 0.89 × 5.33%
Dec 31, 2023 3.52% = 0.78 × 0.88 × 5.14%
Sep 30, 2023 3.63% = 0.78 × 0.89 × 5.27%
Jun 30, 2023 3.89% = 0.77 × 0.90 × 5.64%
Mar 31, 2023 3.89% = 0.77 × 0.90 × 5.60%
Dec 31, 2022 3.87% = 0.77 × 0.90 × 5.54%
Sep 30, 2022 4.09% = 0.77 × 0.91 × 5.83%
Jun 30, 2022 4.13% = 0.77 × 0.91 × 5.89%
Mar 31, 2022 4.37% = 0.77 × 0.91 × 6.24%

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The net profit margin exhibits a sustained downward trajectory over the analyzed period, declining from 4.37% in March 2022 to 2.58% by September 2026. This contraction in overall profitability is the result of combined pressures from operating margins and interest obligations, partially offset by improvements in the tax burden ratio.

EBIT Margin
A significant and consistent erosion of core operating profitability is observed. The EBIT margin decreased from a peak of 6.24% in March 2022 to 3.88% in September 2026. This decline represents the primary driver of the overall reduction in net profit margin, indicating that operating expenses grew at a faster rate than revenue or that pricing power diminished over the five-year span.
Interest Burden
The interest burden ratio shows a gradual decline, moving from 0.91 in early 2022 to 0.81 by September 2026. This downward trend suggests an increasing proportion of operating income is being utilized to service interest expenses, thereby further compressing the transition from operating profit to pre-tax income.
Tax Burden
In contrast to the operating and interest metrics, the tax burden ratio improved over the long term. After remaining stable at 0.77 for much of 2022 and 2023, the ratio trended upward to reach 0.84 by early 2026 before settling at 0.82. This increase indicates a lower effective tax rate over time, which served as a modest mitigating factor against the decline in net profit margin.
Integrated Margin Analysis
The disaggregation reveals that the decline in net profit margin is not attributable to a single factor but is a cumulative effect of operating inefficiency and increased financial leverage. While the tax burden became more favorable, the simultaneous contraction of the EBIT margin and the deterioration of the interest burden resulted in a net loss of approximately 179 basis points in profitability by the end of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?